The MiR142-3p promoter is methylated which decreases miR142-3p gene expression and increases the level of IL-6, thus promoting GBM invasion and migration in a DNA methyltransferase (DNMT) 1-dependent manner (34). This evidence concerns the gene IL6 and glioblastoma.